Chronic-treated HIV: A neurologic disease

Journal of Urban Health

Volumn 77, Issue 2, 2000, Pages 204-212

  Booss, John ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CHRONIC DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; GAIT DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; NEUROLOGIC DISEASE; PAIN; PRIORITY JOURNAL;

EID: 0034042441     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02390531     Document Type: Article

References (17)

1. Sigurdsson B. Observations on three slow infections of sheep. Maedi. Paratuberculosis. Rida, a chronic encephalitis of sheep with general remarks on infections, which develop slowly, and some of their special characteristics. Br Vet J. 1954;110:255-270, 307-322, 341-354.
2. Nathanson N. Neurologic disease produced by visna, maedi and caprine arthritis-encephalitis viruses, lentiviruses of sheep and goats. In Gendelman HE, Lipton SA, Epstein L, Swindells S, eds. The Neurology of AIDS. New York, NY: Chapman and Hall; 1998:179-188.
3. Fauci AS. The AIDS epidemic. Considerations for the 21st century. N Engl J Med. 1999; 341:1046-1050.
4. Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol. 1983;14:403-418.
5. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:517-524.
6. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19:525-535.
7. Shaw GM, Harper ME, Hahn BN, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985;227:177-182.
8. McArthur JC, Grant I. HIV neurocognitive disorders. In Gendelman HE, Lipton SA, Epstein L, Swindells S, eds. The Neurology Of AIDS. New York, NY: Chapman and Hall; 1998:499-523.
9. Navia BA, Price RW. Clinical and biologic features of the AIDS dementia complex. In Gendelman HE, Lipton SA, Epstein L, Swindells S, eds. The Neurology Of AIDS. New York, NY: Chapman and Hall; 1998:229-240.
10. Navia BA, Dafni U, Simpson D, et al. Phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology. 1998;51:221-228.
11. Dore GJ, Correll PK, Yueming Li, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13: 1249-1253.
12. Selwyn PA, Fennie KP, Molde S, et al. Palliative care for people with HIV/AIDS in a dedicated skilled nursing facility. Paper presented at: Twelfth World Conference on AIDS; June 1998; Geneva, Switzerland.
13. Petito CK, Navia BA, Charles E-S, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985;312:874-879.
14. Booss J, Guarnaccia J, Selwyn PA, Friedland GH. HIV neurology in the primary care setting. Paper presented at: Ninth International Conference On AIDS; June 1993; Berlin, Germany.
15. Marra CM, Boutin P, Collier AC. Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings. Neurology. 1998;51:1678-1681.
16. Breitbart W, Rosenfeld B, Passik S, Kaim M, Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain. 1997;72:235-243.
17. D'Aquila R, Walker B. Exploring the benefits and limits of highly active antiretroviral therapy [editorial]. JAMA. 1999;282:1668-1669.